497 related articles for article (PubMed ID: 34638711)
1. Specialized Pro-Resolving Lipid Mediators: The Future of Chronic Pain Therapy?
Chávez-Castillo M; Ortega Á; Cudris-Torres L; Duran P; Rojas M; Manzano A; Garrido B; Salazar J; Silva A; Rojas-Gomez DM; De Sanctis JB; Bermúdez V
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638711
[TBL] [Abstract][Full Text] [Related]
2. [Anti-inflammatory pro-resolving derivatives of omega-3 and omega-6 polyunsaturated fatty acids].
Nowak JZ
Postepy Hig Med Dosw (Online); 2010 Mar; 64():115-32. PubMed ID: 20354260
[TBL] [Abstract][Full Text] [Related]
3. Specialized Pro-Resolving Lipid Mediators: Emerging Therapeutic Candidates for Multiple Sclerosis.
Zahoor I; Giri S
Clin Rev Allergy Immunol; 2021 Apr; 60(2):147-163. PubMed ID: 32495237
[TBL] [Abstract][Full Text] [Related]
4. Possibility of averting cytokine storm in SARS-COV 2 patients using specialized pro-resolving lipid mediators.
Yasmeen N; Selvaraj H; Lakhawat SS; Datta M; Sharma PK; Jain A; Khanna R; Srinivasan J; Kumar V
Biochem Pharmacol; 2023 Mar; 209():115437. PubMed ID: 36731803
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and Changes in Lipid Mediator Profiling after Consumption of Specialized Pro-Resolving Lipid-Mediator-Enriched Marine Oil in Healthy Subjects.
Irún P; Carrera-Lasfuentes P; Sánchez-Luengo M; Belio Ú; Domper-Arnal MJ; Higuera GA; Hawkins M; de la Rosa X; Lanas A
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003333
[TBL] [Abstract][Full Text] [Related]
6. Specialized Proresolving Lipid Mediators: A Potential Therapeutic Target for Atherosclerosis.
Salazar J; Pirela D; Nava M; Castro A; Angarita L; Parra H; Durán-Agüero S; Rojas-Gómez DM; Galbán N; Añez R; Chacín M; Diaz A; Villasmil N; De Sanctis JB; Bermúdez V
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328553
[TBL] [Abstract][Full Text] [Related]
7. Specialized Pro-Resolving Mediators in Neuroinflammation: Overview of Studies and Perspectives of Clinical Applications.
Valente M; Dentoni M; Bellizzi F; Kuris F; Gigli GL
Molecules; 2022 Jul; 27(15):. PubMed ID: 35956787
[TBL] [Abstract][Full Text] [Related]
8. The function of specialized pro-resolving endogenous lipid mediators, vitamins, and other micronutrients in the control of the inflammatory processes: Possible role in patients with SARS-CoV-2 related infection.
Gallo CG; Fiorino S; Posabella G; Antonacci D; Tropeano A; Pausini E; Pausini C; Guarniero T; Hong W; Giampieri E; Corazza I; Loiacono R; Loggi E; de Biase D; Zippi M; Lari F; Zancanaro M
Prostaglandins Other Lipid Mediat; 2022 Apr; 159():106619. PubMed ID: 35032665
[TBL] [Abstract][Full Text] [Related]
9. Neuromodulation, Specialized Proresolving Mediators, and Resolution of Pain.
Tao X; Lee MS; Donnelly CR; Ji RR
Neurotherapeutics; 2020 Jul; 17(3):886-899. PubMed ID: 32696274
[TBL] [Abstract][Full Text] [Related]
10. Specialized Pro-Resolving Mediators as Resolution Pharmacology for the Control of Pain and Itch.
Ji RR
Annu Rev Pharmacol Toxicol; 2023 Jan; 63():273-293. PubMed ID: 36100219
[TBL] [Abstract][Full Text] [Related]
11. Omega-3 Lipid Mediators: Modulation of the M1/M2 Macrophage Phenotype and Its Protective Role in Chronic Liver Diseases.
Videla LA; Valenzuela R; Del Campo A; Zúñiga-Hernández J
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958514
[TBL] [Abstract][Full Text] [Related]
12. Polyunsaturated Fatty Acids: Conversion to Lipid Mediators, Roles in Inflammatory Diseases and Dietary Sources.
Harwood JL
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240183
[TBL] [Abstract][Full Text] [Related]
13. Pro-Resolving Lipid Mediators in the Pathophysiology of Asthma.
Kytikova O; Novgorodtseva T; Denisenko Y; Antonyuk M; Gvozdenko T
Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31216723
[TBL] [Abstract][Full Text] [Related]
14. Immuno-Resolving Ability of Resolvins, Protectins, and Maresins Derived from Omega-3 Fatty Acids in Metabolic Syndrome.
Kwon Y
Mol Nutr Food Res; 2020 Feb; 64(4):e1900824. PubMed ID: 31797565
[TBL] [Abstract][Full Text] [Related]
15. Specialized Pro-Resolving Lipid Mediators: Endogenous Roles and Pharmacological Activities in Infections.
Rasquel-Oliveira FS; Silva MDVD; Martelossi-Cebinelli G; Fattori V; Casagrande R; Verri WA
Molecules; 2023 Jun; 28(13):. PubMed ID: 37446699
[TBL] [Abstract][Full Text] [Related]
16. Molecular Pharmacology of Inflammation Resolution in Atherosclerosis.
Kotlyarov S; Kotlyarova A
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563200
[TBL] [Abstract][Full Text] [Related]
17. The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution.
Serhan CN; Chiang N; Dalli J
Semin Immunol; 2015 May; 27(3):200-15. PubMed ID: 25857211
[TBL] [Abstract][Full Text] [Related]
18. Neuroimmunological effects of omega-3 fatty acids on migraine: a review.
Chen TB; Yang CC; Tsai IJ; Yang HW; Hsu YC; Chang CM; Yang CP
Front Neurol; 2024; 15():1366372. PubMed ID: 38770523
[TBL] [Abstract][Full Text] [Related]
19. Developments of specialized pro-resolving mediators in periodontitis.
Liu YC
Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Feb; 39(1):94-98. PubMed ID: 33723943
[TBL] [Abstract][Full Text] [Related]
20. Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms.
Serhan CN
FASEB J; 2017 Apr; 31(4):1273-1288. PubMed ID: 28087575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]